Ian Sanderson

Chief Financial Officer @Nimbus Therapeutics

Utilizing its powerful structure-based drug discovery engine, Nimbus Therapeutics designs potent and selective small molecule compounds targeting proteins that are known to be fundamental drivers of pathology in highly prevalent human diseases and which have proven difficult for other drug makers to tackle. The company’s LLC/subsidiary architecture enables diverse and synergistic partnerships to deliver breakthrough medicines.